Literature DB >> 25720128

Robust bayesian sensitivity analysis for case-control studies with uncertain exposure misclassification probabilities.

Timothy Shin Heng Mak, Nicky Best, Lesley Rushton.   

Abstract

Exposure misclassification in case-control studies leads to bias in odds ratio estimates. There has been considerable interest recently to account for misclassification in estimation so as to adjust for bias as well as more accurately quantify uncertainty. These methods require users to elicit suitable values or prior distributions for the misclassification probabilities. In the event where exposure misclassification is highly uncertain, these methods are of limited use, because the resulting posterior uncertainty intervals tend to be too wide to be informative. Posterior inference also becomes very dependent on the subjectively elicited prior distribution. In this paper, we propose an alternative "robust Bayesian" approach, where instead of eliciting prior distributions for the misclassification probabilities, a feasible region is given. The extrema of posterior inference within the region are sought using an inequality constrained optimization algorithm. This method enables sensitivity analyses to be conducted in a useful way as we do not need to restrict all of our unknown parameters to fixed values, but can instead consider ranges of values at a time.

Mesh:

Year:  2015        PMID: 25720128     DOI: 10.1515/ijb-2013-0044

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  2 in total

Review 1.  Advances in the genome-wide association study of chronic hepatitis B susceptibility in Asian population.

Authors:  Bing Qiu; Wei Jiang; Mojtaba Olyaee; Kenji Shimura; Akihiro Miyakawa; Huijing Hu; Yongcui Zhu; Lixin Tang
Journal:  Eur J Med Res       Date:  2017-12-28       Impact factor: 2.175

2.  Quantification of missing prescriptions in commercial claims databases: results of a cohort study.

Authors:  Maria Soledad Cepeda; Daniel Fife; Michel Denarié; Dan Bradford; Stephanie Roy; Yingli Yuan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-01-25       Impact factor: 2.890

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.